![]() |
市场调查报告书
商品编码
1987191
实验室过滤市场规模、份额、趋势和预测:按产品类型、技术、最终用户和地区划分,2026-2034年Laboratory Filtration Market Size, Share, Trends and Forecast by Product Type, Technique, End User, and Region, 2026-2034 |
||||||
2025年全球实验室过滤市场规模为47亿美元。展望未来,IMARC集团预测,该市场将在2026年至2034年间以6.37%的复合年增长率成长,到2034年达到83亿美元。目前,北美市场占据主导地位,预计2025年市占率将超过47.09%。北美地区的成长主要得益于生物製药产量的增加、监管要求的日益严格以及实验室中创新过滤技术的普及。此外,生命科学研究的强劲投入以及整个产业对高纯度过滤解决方案日益增长的需求,也推动了该地区实验室过滤市场份额的扩大。
製药和生物技术公司在研发方面投入大量资金,因此需要先进的过滤系统来确保实验和製程的纯度和可靠性。此外,单株抗体、疫苗和细胞疗法等生物製药产品的产量不断增长,也需要先进的过滤技术来维持无菌状态并防止污染,从而创造了有利的市场环境。监管机构也对药品和生物製药的生产实施了更严格的规定,进一步增加了对能够满足这些高标准的过滤系统的需求。此外,技术进步正在推动开发出更有效率、更精确的过滤系统,这些系统具有更强的颗粒和微生物分离能力。最后,一次性过滤系统因其便利性、降低污染风险和减少清洁成本而日益普及,正在推动实验室和生产设施的市场扩张。
美国占据了相当大的市场份额,这主要得益于其强大的製药和生物技术产业,该产业极大地推动了对实验室过滤系统的需求。这些产业高度依赖先进的过滤技术,以确保药物研发、生产和品质保证各阶段的无菌性、纯度和合规性。根据IMARC集团预测,2024年至2032年,美国生技市场预计将以9.50%的复合年增长率成长。此外,美国对创新药物和治疗方法研发计画的巨额投资也对精准可靠的过滤系统提出了更高的要求。过滤技术对于维持实验的完整性、製备样本和扩大生产规模至关重要,从而推动了製药和生物技术领域的创新。
研发活动活性化
不断增长的研发投入推动了对新药、治疗方法和疫苗的需求,进而促进了生物技术和製药产业的成长。实验室过滤产品是其中必不可少的环节,它们对于维持生技药品、个人化疗法和疫苗研发过程中至关重要的无菌性、精确性和可靠性至关重要。报告显示,2020年西班牙各大学和学院在生技相关研发的投入约为4.776亿欧元,创下2009年以来的最高纪录。在分析期间,大学在生物技术研发方面的支出增加了约50%。此外,对先进过滤技术的投资增加、生物製药产品线的扩展以及对药物和疫苗研发的严格监管要求,都进一步推动了市场成长。
慢性病增多
慢性病发生率上升和人口老化是推动实验室过滤市场扩张的主要因素。根据美国国家慢性病预防与健康促进中心的报告估计,美国约有1.29亿人患有至少一种严重的慢性病,例如心臟病、癌症、糖尿病、肥胖或高血压。这种情况需要定期进行诊断检测和后续观察,这就要求过滤系统能够高精度、高可靠性地製备检体,以获得准确的结果。此外,人口老化导致的慢性病盛行率不断上升,也推动了对先进医疗服务的需求。先进的过滤技术正被用于提高诊断准确性,并确保符合严格的医疗标准。这些因素进一步对检查室过滤市场的前景产生了正面影响。
技术进步
自动化系统和检查室的引入正在革新检查室流程,显着提高精度、减少人为误差并提升效率。自动化过滤系统能够以可靠的精度处理大量检体,从而显着加速包括生物製药、化学工程和材料科学在内的众多领域的研发进程。例如,2023年12月,ABB机器人与XtalPi合作,在中国开发了一款自动化实验室工作站,旨在简化生物製药、化学工程和新能源材料领域的研发流程。这些进步确保了符合严格的监管要求,同时最大限度地减少了人力成本和营运成本。由于自动化过滤系统能够处理大量检体,因此它们能够加速实验室的研发进程,并促进实验室过滤市场的收入成长。
The global laboratory filtration market size was valued at USD 4.7 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 8.3 Billion by 2034, exhibiting a CAGR of 6.37% from 2026-2034. North America currently dominates the market, holding a market share of over 47.09% in 2025. The growth of the North American region is driven by increasing biopharmaceutical production, strict regulatory requirements, and high adoption of innovative filtration technologies in laboratories. The region's increasing laboratory filtration market share is further attributed to robust investments in life sciences research and the rising demand for high-purity filtration solutions across industries.
Pharmaceutical and biotechnology firms are dedicating significant funds to research and development (R&D), necessitating top-notch filtration systems to ensure the purity and dependability of experiments and procedures. Moreover, the increasing manufacturing of biologics such as monoclonal antibodies, vaccines, and cell therapies, necessitating sophisticated filtration technologies to maintain sterility and avoid contamination, is presenting a positive market perspective. In addition, regulatory agencies are implementing stringent regulations for the production of drugs and biologics, resulting in an increased demand for filtration systems that can adhere to these elevated standards. Apart from this, advancements in technology are driving the creation of more effective and accurate filtration systems, allowing for enhanced separation of particles and microorganisms. Furthermore, the increasing adoption of single-use systems, known for their convenience, lower contamination risks, and reduced cleaning expenses, is driving the market expansion in laboratories and production facilities.
The United States is an essential part of the market, propelled by a strong pharmaceutical and biotechnology industry that greatly fuels the need for laboratory filtration systems. These sectors depend significantly on cutting-edge filtration technologies to ensure sterility, purity, and adherence to regulations throughout drug development, production, and quality assurance stages. According to the IMARC Group, the biotechnology market in the US is projected to have a compound annual growth rate (CAGR) of 9.50% between 2024 and 2032. In addition, significant investments made by the country in research programs for innovative medications and treatments require accurate and dependable filtration systems. Filtration is crucial for maintaining the integrity of experiments, preparing samples, and scaling up processes, fostering innovation in the pharmaceutical and biotechnology sectors.
Rising R&D Activities
The demand for new drugs, therapies, and vaccines is rising because of the increase in research and development efforts, which is contributing to growth within the biotechnology and pharmaceutical industries. The items required include laboratory filtration products. These are required to maintain sterility, precision, and dependability in research activities that are necessary to create biologics, tailored therapies, and vaccines. According to reports, in 2020, universities and colleges in Spain allocated about 477.6 million euros for biotechnology-associated research and development, which was the highest amount since 2009. During the period of analysis, universities increased their biotech R&D expenditures by about 50%. Additionally, growing investments in advanced filtration technologies, an expanding scope of biopharmaceutical pipelines, and stringent regulatory requirements for the development of drugs and vaccines further fuel the market growth.
Growing Prevalence of Chronic Diseases
The rise in chronic illnesses and the aging demographic are major factors contributing to the expansion of the laboratory filtration market. An article from the National Center for Chronic Disease Prevention and Health Promotion estimates that around 129 million individuals in the United States have at least one significant chronic condition, such as heart disease, cancer, diabetes, obesity, and hypertension. These circumstances demand regular diagnostic testing and oversight, calling for filtration systems to prepare samples with great accuracy and dependability for precise outcomes. Moreover, the elderly population leads to a greater incidence of chronic illnesses, which escalates the need for sophisticated healthcare options. The utilization of advanced filtration technologies to enhance diagnostic precision and adhere to strict healthcare standards. These factors are further positively influencing the laboratory filtration market forecast.
Technological Advancements
The incorporation of automated systems and robotics in laboratories is improving accuracy, minimizing human mistakes, and boosting efficiency, thus revolutionizing laboratory processes. Automated filtration systems are capable of processing vast amounts of samples with reliable precision, greatly speeding up the research and development process in multiple areas, such as biopharmaceuticals, chemical engineering, and materials science. For example, in December 2023, ABB Robotics collaborated with XtalPi to create automated lab workstations in China, designed to enhance R&D efficiency in biopharmaceuticals, chemical engineering, and new energy materials. These advancements minimize manual work and operational expenses while guaranteeing adherence to stringent regulatory requirements. Automated filtration systems can handle a large volume of samples, thus speeding up the research and development process in laboratories and boosting the laboratory filtration market revenue.
Filtration media stands as the largest component in 2025, holding 53.5% of the market share. As per the laboratory filtration market forecast, filtration media refer to materials employed in filtration methods to eliminate particles, pollutants, and impurities from fluids (liquids or gases). These media are designed to permit the fluid to flow while efficiently capturing or eliminating undesirable materials, guaranteeing the intended purity level. They are essential in numerous applications, such as drug discovery, biotechnology, and environmental testing, where accuracy and cleanliness are crucial. The increasing investment in research and development for drug discovery and creation requires high-quality filtration media to guarantee purity, precision, and consistency in experiments, thus boosting demand. Filtration media like membrane filters, depth filters, and activated carbon filters are designed for particular uses, increasing their effectiveness. The increasing occurrence of chronic illnesses and the corresponding advancement of biologics, vaccines, and tailor-made medications also drive the need for sophisticated filtration materials. Moreover, strict regulatory standards and the growing emphasis on sustainability are driving advancements in eco-friendly and reusable filtration materials.
Microfiltration leads the market with 36.5% of the market share in 2025. According to the laboratory filtration market overview, microfiltration (MF) is a widely used technique essential for separating particles and microorganisms from fluids. It employs membrane filters with pore sizes typically ranging from 0.1 to 10 micrometers, making it particularly effective for removing bacteria, suspended solids, and larger particles. High purity and sterility are critical for producing drugs, biologics, and vaccines, driving the need for microfiltration to eliminate microorganisms and particulates. This technique is indispensable in biopharmaceutical manufacturing, where contamination-free processes are paramount. MF is also widely applied in sample preparation, effectively removing particulates that could interfere with analytical techniques such as chromatography and spectroscopy, ensuring accurate and reliable results. Additionally, microfiltration is employed in environmental testing, food and beverage processing, and water purification, emphasizing its versatility. The growing adoption of disposable filtration systems in laboratories and increasing regulatory requirements for sterility further enhance the demand for MF in various industries.
Pharmaceutical and biopharmaceutical companies lead the market because of their significant utilization of filtration technologies in drug creation, manufacturing, and quality control procedures. These businesses depend on sophisticated filtration systems to guarantee the purity and effectiveness of their products, adhere to strict regulatory standards, and uphold contamination-free settings. The expanding portfolio of biologics, vaccines, and personalized medicines enhances the need for filtration solutions, especially for sterile filtration, virus filtration, and ultrafiltration uses. Biopharmaceutical companies, specifically, gain advantages from filtration systems with high capacity designed for the manufacturing of monoclonal antibodies, recombinant proteins, and cell and gene therapies. Moreover, the rising incidence of chronic illnesses and the worldwide focus on drug development stimulate investments in advanced filtration technologies. Partnerships between filtration system suppliers and pharmaceutical companies to create tailored, effective solutions further strengthen this supremacy. This trend is supported by the increasing emphasis on sustainability, encouraging reusable and energy-saving filtration systems.
In 2025, North America accounted for the largest market share of 47.09%. According to the laboratory filtration market statistics, the well-established pharmaceutical and biopharmaceutical manufacturing industries in North America drive the need for advanced laboratory filtration to ensure product quality and strict compliance with the regulatory environment. Meanwhile, intense R&D activities in these industries require highly reliable filtration equipment for sample preparation, purification, and analysis. Moreover, nanofiltration and ultrafiltration among other developments in membrane technology enhance the performance and effectiveness of laboratory filtration equipment. In addition, the introduction of novel membrane filter products and related filtration systems is expected to drive regional market growth through the forecast period. For example, in November 2021, DuPont Water Solutions (DWS) launched the TapTec LC HF-4040 reverse osmosis membrane filter, which offers high flow rates while remaining dependable.
UNITED STATES LABORATORY FILTRATION MARKET ANALYSIS
In North America, the United States is a crucial segment, holding 86.70% market share in 2025. Laboratory filtration in the United States has been gaining pace primarily because of an increase in healthcare sector investment, which has significantly risen in recent times. According to JP Morgan, Seed and Series A funding into U.S. biopharma companies totaled USD 5.1 Billion across 105 rounds in the first half of 2024. With an expanding focus on healthcare infrastructure, there has been a surge in the demand for advanced filtration technologies that ensure the purification of water, chemicals, and biological samples, thus supporting research and diagnostics. This investment in healthcare also fuels the growth of better filtration solutions in response to the changing needs of laboratories to maintain precision and safety. In addition, the tighter the regulatory measures are, the more dependent laboratories become on filtration systems when meeting safety and quality standards. This combination of increased funding and the need for cutting-edge filtration solutions is propelling the widespread adoption of laboratory filtration across various medical and research fields.
EUROPE LABORATORY FILTRATION MARKET ANALYSIS
In Europe, increased chronic diseases and an aging population have further increased the demand for efficient laboratory filtration systems. For instance, the elderly population is growing in Europe, with one in every five Europeans aged 65 years or older estimated to reach nearly 30% by 2050. With the population aging, there is a resulting rising need for diagnostic tests and therapies concerning chronic illnesses like heart disease, diabetes, and respiratory disorders. It is against this demographic change that laboratories are investing in state-of-the-art filtration technologies that upgrade accurate procedures for diagnoses and protect the patient's safety. More and more laboratories are conducting complex research and clinical studies, hence increasing the demand for superior filtration systems. The growing interest in public health and the prevention of diseases has made healthcare providers take on the implementation of advanced technologies that enhance the quality of life of the elderly. Laboratory filtration systems are also very important in ensuring that tests, samples, and medical devices are safeguarded and comply strictly with health and safety regulations.
ASIA PACIFIC LABORATORY FILTRATION MARKET ANALYSIS
In the Asia-Pacific area, the increasing focus on healthcare improvements has notably enhanced the use of laboratory filtration technologies. The Ministry of Commerce and Industry, India, reports that there are 1162 investment projects totaling USD 31.47 Billion in the healthcare sector throughout various states in India. The growing emphasis on advancing healthcare infrastructure and medical research skills has driven the need for filtration systems that improve research results, diagnostics, and safety for patients. Improvements in medical device technology, along with increasing healthcare costs, are prompting labs to adopt filtration systems that provide cleaner and safer workspaces. These advancements enable laboratories to attain improved accuracy in tests and experiments, especially in crucial areas such as pharmaceuticals and diagnostics. Furthermore, the healthcare industry's dedication to adopting advanced technologies to address new diseases and enhance public health has laid a robust groundwork for the ongoing use of filtration systems.
LATIN AMERICA LABORATORY FILTRATION MARKET ANALYSIS
The expansion of the private healthcare system in Latin America has played a crucial role in the increasing use of laboratory filtration technologies. As per the International Trade Administration, Brazil boasts the largest healthcare market in Latin America, featuring 7,191 hospitals, with 62% being private institutions. With the ongoing growth of the private healthcare industry, there is increasing focus on upholding excellent standards in medical testing and diagnostics. This has resulted in a greater demand for trustworthy filtration systems to guarantee the cleanliness of samples and materials utilized in medical procedures. Laboratories in the area are putting resources into sophisticated filtration technologies to meet the need for precise and reliable diagnostic outcomes. Moreover, private healthcare organizations seek to provide competitive services, necessitating their adoption of the newest technologies in medical testing, such as filtration systems. The growing presence of private healthcare institutions is leading to an escalating need for efficient laboratory filtration systems.
MIDDLE EAST AND AFRICA LABORATORY FILTRATION MARKET ANALYSIS
The growth of hospitals and diagnostic laboratories in the Middle East and Africa has driven the demand for laboratory filtration systems. According to Dubai Healthcare City Authority report, Dubai's healthcare sector saw rapid growth, with 4,482 private medical facilities and 55,208 licensed professionals by 2022, projected to expand further by 3-6% in facilities and 10-15% in professionals in 2023. With an expanding healthcare infrastructure, there is a growing need for high-quality filtration technologies to ensure the purity of samples and testing environments. Laboratories in the region are increasingly adopting filtration solutions to meet the rising standards of diagnostic accuracy and safety. Additionally, with the ongoing development of healthcare services to meet the needs of a growing and diverse population, filtration systems are becoming an integral part of laboratory setups. This shift is essential for ensuring the reliability of tests, improving healthcare outcomes, and complying with international standards for medical research and patient care. The rise of medical facilities is thus pushing the adoption of advanced filtration solutions across the region.
Major participants in the market are concentrating on strategic actions to enhance their market standing and address changing industry needs. This entails developing advanced filtration techniques to enhance efficiency, precision, and scalability in various applications. Companies are making substantial investments in research efforts to create advanced filtration systems tailored to pharmaceutical, biotechnology, and industrial needs. Through broadening their range of products and establishing partnerships or purchasing other firms, they can expand their market reach and grow their user base. Major companies are highlighting sustainable practices by providing reusable and environment-friendly filtration products to tackle ecological issues. In 2024, Sartorius introduced the Vivaflow(R) SU, an advanced tangential flow filtration (TFF) cassette aimed at research scientists. This disposable, integrated cassette simplifies usability, optimizes ultrafiltration procedures, and boosts sustainability by cutting plastic usage by 30.5%. It streamlines molecule concentration and rebuffering, removing complicated calculations and reducing waste.